Bionano Genomics, Inc. (BNGO): Nasdaq/NYSE listing notice — Bionano Genomics receives Nasdaq delisting notice for bid price below $1.00

Bionano Genomics, Inc.

Nasdaq notified Bionano on May 30, 2023 that its common stock bid price closed below $1.00 for 30 consecutive days.
Company has 180 days to regain compliance by having closing bid price at least $1.00 for 10 consecutive business days.
If not compliant, may be eligible for additional 180-day grace period if other listing standards are met.
Stock continues to trade under symbol BNGO on Nasdaq Capital Market pending compliance.
Company intends to monitor and consider options to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Bionano Genomics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 30, 2023, Bionano Genomics, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice has no effect on the listing of the Company’s common stock at this time, and the Company’s common stock continues to trade on The Nasd

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Bionano Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-028021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.